BioNexus Gene Lab Corp has announced a modification in rights of security holders due to a reverse stock split of common stock at a ratio of one-for-ten. However, the ratio was later revised from one-for-ten to one-for-twelve. This action does not alter the par value or modify any voting rights, changing the CUSIP number to 090628207.